Your browser doesn't support javascript.
loading
Mostrar:20 |50 |100
Resultados 1 -10 de 10
Filtrar
Mais filtros













Base de dados
Intervalo de ano de publicação
1.
Eur J Emerg Med ;31(1): 29-38, 2024 Feb 01.
ArtigoemInglês |MEDLINE | ID: mdl-37729041

RESUMO

BACKGROUND AND IMPORTANCE: The rates of hidden infection and late diagnosis of HIV still remain high in Western countries. Missed diagnostic opportunities represent the key point in changing the course of the epidemic. OBJECTIVE: To evaluate the feasibility and results of implementation of a selective strategy to test for HIV in the emergency department (ED) in patients with six pre-defined medical situations: sexually transmitted infections, herpes zoster, community-acquired pneumonia, mononucleosis syndrome, practice of chemsex (CS) or request of post-exposure prophylaxis. DESIGN: This quasi-experimental longitudinal study evaluated the pre- and post-implementation results of HIV testing in the six aforementioned clinical scenarios. SETTINGS AND PARTICIPANTS: Patients attended 34 Spanish EDs. INTERVENTION OR EXPOSURE: The intervention was an intensive educational program and pathways to facilitate and track orders and results were designed. We collected and compared pre- and post-implementation ED census and diagnoses, and HIV tests requested and results. OUTCOME MEASURES AND ANALYSIS: The main outcome was adherence to the recommendations. Secondary outcomes were to evaluate the effectiveness of the program by the rate of positive test and the new HIV diagnoses. Differences between first and second periods were assessed. The magnitude of changes (absolute and relative) was expressed with the 95% confidence interval (CI). MAIN RESULTS: HIV tests increasing from 7080 (0.42% of ED visits) to 13 436 (relative increase of 75%, 95% CI from 70 to 80%). The six conditions were diagnosed in 15 879 and 16 618 patients, and HIV testing was ordered in 3393 (21%) and 7002 (42%) patients (increase: 97%; 95% CI: 90-104%). HIV testing significantly increased for all conditions except for CS. The positive HIV test rates increased from 0.92 to 1.67%. Detection of persons with undiagnosed HIV increased from 65 to 224, which implied a 220% (95% CI: 143-322%) increase of HIV diagnosis among all ED comers and a 71% (95% CI: 30-125%) increase of positive HIV tests. CONCLUSION: Implementation of a strategy to test for HIV in selective clinical situations in the ED is feasible and may lead to a substantial increase in HIV testing and diagnoses.


Assuntos
Infecções por HIV, Humanos, Infecções por HIV/diagnóstico, Infecções por HIV/epidemiologia, Estudos Controlados Antes e Depois, Estudos de Viabilidade, Estudos Longitudinais, Programas de Rastreamento/métodos, Teste de HIV, Serviço Hospitalar de Emergência
2.
ArtigoemInglês |MEDLINE | ID: mdl-37328343

RESUMO

Early diagnosis of HIV is still a challenge. Emergency Departments (EDs) suppose ideal settings for the early detection of HIV, since patients with high prevalence of hidden HIV infection are frequently attending those services. In 2020, the Spanish Society of Emergency and Emergency Medicine (SEMES) published a series of recommendations for the early diagnosis of patients with suspected HIV infection and their referral and follow-up in the EDs as part of its "Deja tu huella" program. However, the application of these recommendations has been very heterogeneous in our country. Considering this, the working group of the HIV hospital network led by the SEMES has motivated the drafting of a decalogue, with the aim of promoting the implementation and improvement of protocols for the early diagnosis of HIV in Spanish EDs.

3.
Respir Res ;23(1): 221, 2022 Aug 28.
ArtigoemInglês |MEDLINE | ID: mdl-36031619

RESUMO

BACKGROUND: Mid-Regional pro-Adrenomedullin (MR-proADM) is an inflammatory biomarker that improves the prognostic assessment of patients with sepsis, septic shock and organ failure. Previous studies of MR-proADM have primarily focussed on bacterial infections. A limited number of small and monocentric studies have examined MR-proADM as a prognostic factor in patients infected with SARS-CoV-2, however there is need for multicenter validation. An evaluation of its utility in predicting need for hospitalisation in viral infections was also performed. METHODS: An observational retrospective analysis of 1861 patients, with SARS-CoV-2 confirmed by RT-qPCR, from 10 hospitals across Europe was performed. Biomarkers, taken upon presentation to Emergency Departments (ED), clinical scores, patient demographics and outcomes were collected. Multiclass random forest classifier models were generated as well as calculation of area under the curve analysis. The primary endpoint was hospital admission with and without death. RESULTS: Patients suitable for safe discharge from Emergency Departments could be identified through an MR-proADM value of ≤ 1.02 nmol/L in combination with a CRP (C-Reactive Protein) of ≤ 20.2 mg/L and age ≤ 64, or in combination with a SOFA (Sequential Organ Failure Assessment) score < 2 if MR-proADM was ≤ 0.83 nmol/L regardless of age. Those at an increased risk of mortality could be identified upon presentation to secondary care with an MR-proADM value of > 0.85 nmol/L, in combination with a SOFA score ≥ 2 and LDH > 720 U/L, or in combination with a CRP > 29.26 mg/L and age ≤ 64, when MR-proADM was > 1.02 nmol/L. CONCLUSIONS: This international study suggests that for patients presenting to the ED with confirmed SARS-CoV-2 infection, MR-proADM in combination with age and CRP or with the patient's SOFA score could identify patients at low risk where outpatient treatment may be safe.


Assuntos
Adrenomedulina, COVID-19, Hospitalização, Adrenomedulina/análise, Biomarcadores, Proteína C-Reativa, COVID-19/mortalidade, Mortalidade Hospitalar, Humanos, Prognóstico, Precursores de Proteínas, Estudos Retrospectivos, SARS-CoV-2
4.
Front Immunol ;12: 726960, 2021.
ArtigoemInglês |MEDLINE | ID: mdl-34671348

RESUMO

Objectives: In the context of the Covid-19 pandemic, the fast development of vaccines with efficacy of around 95% preventing Covid-19 illness provides a unique opportunity to reduce the mortality associated with the pandemic. However, in the absence of efficacious prophylactic medications and few treatments for this infection, the induction of a fast and robust protective immunity is required for effective disease control, not only to prevent the disease but also the infection and shedding/transmission. The objective of our study was to analyze the level of specific humoral and cellular T-cell responses against the spike protein of SARS-CoV-2 induced by two mRNA-based vaccines (BNT162b2 and mRNA-1273), but also how long it takes after vaccination to induce these protective humoral and cellular immune responses. Methods: We studied in 40 healthy (not previously infected) volunteers vaccinated with BNT162b2 or mRNA-1273 vaccines the presence of spike-specific IgG antibodies and SARS-CoV-2-specific T cells at 3, 7 and 14 days after receiving the second dose of the vaccine. The specific T-cell response was analyzed stimulating fresh whole blood from vaccinated volunteers with SARS-CoV-2 peptides and measuring the release of cytokines secreted by T cells in response to SARS-CoV-2 stimulation. Results: Our results indicate that the immunization capacity of both vaccines is comparable. However, although both BNT162b2 and mRNA-1273 vaccines can induce early B-cell and T-cell responses, these vaccine-mediated immune responses do not reach their maximum values until 14 days after completing the vaccination schedule. Conclusion: This refractory period in the induction of specific immunity observed after completing the vaccination could constitute a window of higher infection risk, which could explain some emerging cases of SARS-CoV-2 infection in vaccinated people.


Assuntos
Anticorpos Antivirais/sangue, Vacinas contra COVID-19/imunologia, Imunogenicidade da Vacina/imunologia, SARS-CoV-2/imunologia, Linfócitos T/imunologia, Vacina de mRNA-1273 contra 2019-nCoV, Adulto, Anticorpos Neutralizantes/imunologia, Vacina BNT162, COVID-19/prevenção & controle, Feminino, Humanos, Imunidade Celular/imunologia, Imunidade Humoral/imunologia, Esquemas de Imunização, Imunoglobulina G/sangue, Contagem de Linfócitos, Masculino, Estudos Prospectivos, Vacinação
5.
Microbiol Spectr ;9(1): e0033621, 2021 09 03.
ArtigoemInglês |MEDLINE | ID: mdl-34431684

RESUMO

Nasopharyngeal (NP) specimens are commonly used for the detection of influenza, but saliva swabs are easier to obtain and cause less discomfort to the patients. The objective of this study was to evaluate the usefulness of saliva swab specimens for the diagnosis of influenza compared with NP specimens. Influenza virus detection rate in saliva and NP swabs was compared in adult patients admitted to an emergency department from January to March 2020, using the Xpert Xpress Flu/respiratory syncytial virus (RSV) test. Cycle threshold (CT) values were evaluated in all the cases. Among the 82 patients recruited, 19 had an influenza-positive diagnostic test result (11 influenza A and 8 influenza B). Overall, the agreement between saliva and NP swabs results was 97.6% (80/82; κ = 0.929; 95% confidence interval [CI], 0.832 to 1.0). There was no significant difference in the influenza detection rate between saliva swab and NP specimens (20.7% [17/82] versus 23.2% [19/82]; P = 0.5). There were only two discordant results (influenza B in an NP and false negative in a saliva sample). Manual inspection of the amplification curves showed that influenza RNA had been amplified in saliva with high CTs (CT of 40) that the test reported as a negative result. The overall sensitivity and specificity for saliva was 89.5% (73.0% to 100%) and 100% (99.2% to 100%), respectively. In all the cases, the same influenza virus (A/B) was detected. Median CT values were significantly lower in NP (31; interquartile range [IQR], 21.0 to 32.0) than in saliva (33; IQR, 23.0 to 38.0) (P = 0.001) specimens. Saliva swabs have high sensitivity and specificity for the detection of influenza virus by the Xpert Xpress Flu/RSV test and a high overall agreement and CT correlation with NP specimens. Saliva swab is a feasible specimen type for influenza testing that might be easily self-collected with minimal equipment and discomfort. IMPORTANCE Early detection of influenza virus is important for guiding antiviral and antibacterial treatment for infection control and public health measures. We have observed that saliva swab specimens have high sensitivity and specificity for the detection of influenza by the Xpert Xpress Flu/respiratory syncytial virus (RSV) test and high overall agreement and CT correlation with nasopharyngeal specimens. Saliva swab may therefore be a feasible specimen type for influenza testing that can be easily self-collected with minimal equipment and discomfort.


Assuntos
Serviço Hospitalar de Emergência, Saliva/virologia, Manejo de Espécimes/métodos, Idoso, Idoso de 80 Anos ou mais, Antivirais, Testes Diagnósticos de Rotina, Feminino, Humanos, Vírus da Influenza A/genética, Influenza Humana/diagnóstico, Influenza Humana/virologia, Masculino, Pessoa de Meia-Idade, Nasofaringe/virologia, Infecções por Vírus Respiratório Sincicial/genética, Infecções por Vírus Respiratório Sincicial/virologia, Vírus Sincicial Respiratório Humano, Sensibilidade e Especificidade, Carga Viral
6.
Expert Rev Mol Diagn ;21(4): 397-404, 2021 04.
ArtigoemInglês |MEDLINE | ID: mdl-33736553

RESUMO

INTRODUCTION: Mid-regional proadrenomedullin (MR-proADM), a novel biomarker, has recently gained interest particularly with regards to its potential in assisting clinicians' decision making in patients with suspicion of infection in the emergency department (ED). A group of international experts, with research and experience in MR-proADM applications, produced this review based on their own experience and the currently available literature. AREAS COVERED: The review provides evidence related to MR-proADM as a triaging tool in avoiding unnecessary admissions to hospital and/or inadequate discharge, and identifying patients most at risk of deterioration. It also covers the use of MR-proADM in the context of COVID-19. Moreover, the authors provide a proposal on how to incorporate MR-proADM into patients' clinical pathways in an ED setting. EXPERT OPINION: The data we have so far on the application of MR-proADM in the ED is promising. Incorporating it into clinical scoring systems may aid the clinician's decision making and recognizing the 'ill looking well' and the 'well looking ill' sooner. However there are still many gaps in our knowledge especially during the ongoing COVID-19 waves. There is also a need for cost-effectiveness analysis studies especially in the era of increasing cost pressures on health systems globally.


Assuntos
Adrenomedulina/sangue, Biomarcadores/sangue, COVID-19/etiologia, Infecções/sangue, Precursores de Proteínas/sangue, Algoritmos, Antibacterianos/uso terapêutico, COVID-19/sangue, COVID-19/mortalidade, Procedimentos Clínicos, Testes Diagnósticos de Rotina, Serviço Hospitalar de Emergência, Mortalidade Hospitalar, Humanos, Infecções/etiologia, Índice de Gravidade de Doença
7.
Crit Care ;24(1): 691, 2020 12 14.
ArtigoemInglês |MEDLINE | ID: mdl-33317616

RESUMO

BACKGROUND: COVID-19 can course with respiratory and extrapulmonary disease. SARS-CoV-2 RNA is detected in respiratory samples but also in blood, stool and urine. Severe COVID-19 is characterized by a dysregulated host response to this virus. We studied whether viral RNAemia or viral RNA load in plasma is associated with severe COVID-19 and also to this dysregulated response. METHODS: A total of 250 patients with COVID-19 were recruited (50 outpatients, 100 hospitalized ward patients and 100 critically ill). Viral RNA detection and quantification in plasma was performed using droplet digital PCR, targeting the N1 and N2 regions of the SARS-CoV-2 nucleoprotein gene. The association between SARS-CoV-2 RNAemia and viral RNA load in plasma with severity was evaluated by multivariate logistic regression. Correlations between viral RNA load and biomarkers evidencing dysregulation of host response were evaluated by calculating the Spearman correlation coefficients. RESULTS: The frequency of viral RNAemia was higher in the critically ill patients (78%) compared to ward patients (27%) and outpatients (2%) (p < 0.001). Critical patients had higher viral RNA loads in plasma than non-critically ill patients, with non-survivors showing the highest values. When outpatients and ward patients were compared, viral RNAemia did not show significant associations in the multivariate analysis. In contrast, when ward patients were compared with ICU patients, both viral RNAemia and viral RNA load in plasma were associated with critical illness (OR [CI 95%], p): RNAemia (3.92 [1.183-12.968], 0.025), viral RNA load (N1) (1.962 [1.244-3.096], 0.004); viral RNA load (N2) (2.229 [1.382-3.595], 0.001). Viral RNA load in plasma correlated with higher levels of chemokines (CXCL10, CCL2), biomarkers indicative of a systemic inflammatory response (IL-6, CRP, ferritin), activation of NK cells (IL-15), endothelial dysfunction (VCAM-1, angiopoietin-2, ICAM-1), coagulation activation (D-Dimer and INR), tissue damage (LDH, GPT), neutrophil response (neutrophils counts, myeloperoxidase, GM-CSF) and immunodepression (PD-L1, IL-10, lymphopenia and monocytopenia). CONCLUSIONS: SARS-CoV-2 RNAemia and viral RNA load in plasma are associated with critical illness in COVID-19. Viral RNA load in plasma correlates with key signatures of dysregulated host responses, suggesting a major role of uncontrolled viral replication in the pathogenesis of this disease.


Assuntos
COVID-19/complicações, RNA Viral/análise, Carga Viral/imunologia, Adulto, Idoso, Biomarcadores/análise, Biomarcadores/sangue, COVID-19/sangue, Distribuição de Qui-Quadrado, Estado Terminal, Feminino, Humanos, Masculino, Pessoa de Meia-Idade, Análise Multivariada, Reação em Cadeia da Polimerase/métodos, RNA Viral/sangue, Estatísticas não Paramétricas
9.
Eur J Hosp Pharm ;27(2): 73-77, 2020 03.
ArtigoemInglês |MEDLINE | ID: mdl-32133132

RESUMO

Objectives: To determine if an advanced medication review carried out in the emergency department (ED) increases the number of pharmacotherapy recommendations (PR) and the severity of the detected prescribing errors. Methods: We designed an analytic observational prospective cohort study with preintervention assessment (PRE) and postintervention assessment (POST). In PRE, prescription review was done by pharmacists located in the pharmacy department; they took into account only the information provided by the computerised physician order entry system. In POST, pharmacists were physically present in the ED and performed an advanced medication review. The main variables were number of PR and the severity of detected prescribing errors according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) severity index. Clinical variables were number of calls to physicians on duty during the first 48 hours of admission, readmissions at 30 days, visits to the ED at 30 days, inhospital mortality and length of stay. Results: The study population comprised 102 patients (51 in PRE and 51 in POST). In PRE, the number of PR per patient was 1.1; in POST, this value increased by 53% (1.7 PR per patient; P=0.014), especially in the case of PR related to home medications. The severity of prescribing errors was higher in POST (P=0.004). There was a trend towards better results for all clinical outcomes in POST although statistical significance was not reached. Conclusions: An advanced medication review in the ED increases the number of PR and the severity of the detected prescribing errors.


Assuntos
Serviço Hospitalar de Emergência, Erros de Medicação/prevenção & controle, Reconciliação de Medicamentos/métodos, Serviço de Farmácia Hospitalar/métodos, Idoso, Idoso de 80 Anos ou mais, Estudos de Coortes, Serviço Hospitalar de Emergência/normas, Feminino, Humanos, Masculino, Reconciliação de Medicamentos/normas, Pessoa de Meia-Idade, Serviço de Farmácia Hospitalar/normas, Estudos Prospectivos, Estudos Retrospectivos
10.
Emergencias ;27(4): 267-279, 2015.
ArtigoemEspanhol |MEDLINE | ID: mdl-29087083

RESUMO

EN: The objective of this study is to describe similarities and differences between the proposed residency program in emergency medicine (EM) and the established programs in internal medicine, intensive care medicine, anesthesia and recovery care, and family and community practice. The training program drafted by the committee to promote specialization in EM, convened by the Spanish Society of Emergency Medicine (SEMES), was compared to those of the 4 above-mentioned residency programs published on the web page of the Spanish Ministry of Health, Social Services, and Equality as they appeared in June 2015. Points of comparison with the SEMES committee's proposal were the general definitions, scope of practice, and aims of each program; the rotations included; the organization of on-call responsibilities; and specific aspects of emergency care knowledge, skills, and techniques the residencies include in their curricula. The programs were found to be similar in their training plans for managing acute conditions and they had common aims regarding quality of care, organization and management, and research methodology. Differences between the EM proposal and the other residencies were found in the implementation of triage in multiple scenarios; integrated care for patients with mild to critical conditions; the approach to training, workplace organization, and research during regular shifts and oncall periods; training in out-of-hospital emergency situations; and the management of emergency care in catastrophes. It is concluded that EM has a character of its own, with features that distinguish it from other specializations and that are relevant to overall, specific, and practical aspects of training in both hospital and out-of-hospital emergency care.


ES: El objetivo del estudio es escribir las similitudes y diferencias de los programas docentes de las especialidades de Medicina de Urgencias y Emergencias (MUE), Medicina Interna (MI), Medicina Intensiva (MIV), Anestesiología y Reanimación (AyR) y Medicina Familiar y Comunitaria (MFyC). Se comparan los programas formativos oficiales de MI, MIV, AyR y MFyC que figuran en junio de 2015 en el portal del Ministerio de Sanidad, Servicios Sociales e Igualdad y el de la Comisión Promotora de la especialidad de MUE elaborado por la Sociedad Española de Medicina de Urgencias y Emergencias. Así como las definiciones, campo de actuación, objetivos generales, rotaciones, programa de guardias, y los conocimientos, habilidades y técnicas específicas de las atenciones urgentes incluidas en todos programas en relación con la especialidad de MUE. De los programas que se presentan, se ha encontrado un paralelismo en todos ellos en cuanto al desarrollo formativo en la atención a la patología aguda y aspectos formativos comunes a todos los médicos internos residentes: calidad, gestión y metodología de la investigación. Se evidencian hechos diferenciadores y propios en el programa docente de la MUE en: la capacidad de realizar triaje en múltiples escenarios, la atención integral desde el paciente leve al paciente crítico, el desarrollo docente, laboral e investigador en los servicios de urgencias tanto en periodo laboral ordinario como en guardias, la formación en el ámbito de las urgencias extrahospitalarias, así como la gestión y asistencia en grandes catástrofes y en emergencias médicas. Se concluye que la MUE tiene una entidad propia, que pone de manifiesto aspectos diferenciadores respecto al resto de especialidades en cuanto a la formación global, específica y real, en el ámbito de las urgencias hospitalarias y emergencias extrahospitalarias.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...